Literature DB >> 2659724

Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.

A S Cross1, J C Sadoff, N Kelly, E Bernton, P Gemski.   

Abstract

Tumor necrosis factor/cachectin (TNF/C) is the principal mediator of bacterial endotoxin-induced shock and death. We found that the C3H/HeJ mouse, which is less able to produce TNF/C in response to endotoxin, has a 1,000-fold greater susceptibility to lethal infection with Escherichia coli than the TNF-responsive congenic mouse, C3H/HeN. This surprising finding suggested that this lethal peptide may also be involved in host protection. To test this hypothesis we pretreated the C3H/HeJ mouse with a combination of recombinant murine TNF/C-alpha and IL-1 alpha. This combination protected these mice against an intraperitoneal bacterial challenge of greater than 20 LD50S (nearly 2 x 10(2) CFU) that grew to a level of greater than 10(7) CFU/ml of blood and per gram of liver in untreated mice. This suggests a significant role for these cytokines in host defenses against invasive infections that require bacterial replication within the host. These protective mechanisms may not be important for less virulent organisms. These findings may have important implications for the proposed use of anti-TNF/C agents in the treatment of septic shock.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2659724      PMCID: PMC2189352          DOI: 10.1084/jem.169.6.2021

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  Antibacterial activity of recombinant murine beta interferon.

Authors:  T Fujiki; A Tanaka
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

Review 2.  Tumor necrosis factor and interleukin 1 as mediators of endotoxin-induced beneficial effects.

Authors:  R Urbaschek; B Urbaschek
Journal:  Rev Infect Dis       Date:  1987 Sep-Oct

3.  Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria.

Authors:  G E Grau; L F Fajardo; P F Piguet; B Allet; P H Lambert; P Vassalli
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

4.  Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection.

Authors:  A Nakane; T Minagawa; K Kato
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

5.  Effect of recombinant human interleukin-2 on the course of experimental chronic respiratory tract infection caused by Klebsiella pneumoniae in mice.

Authors:  Y Iizawa; T Nishi; M Kondo; K Tsuchiya; A Imada
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

6.  Human granulocyte-macrophage colony-stimulating factor induces expression of the tumor necrosis factor gene by the U937 cell line and by normal human monocytes.

Authors:  S A Cannistra; A Rambaldi; D R Spriggs; F Herrmann; D Kufe; J D Griffin
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

7.  Recombinant tumor necrosis factor/cachectin and interleukin 1 pretreatment decreases lung oxidized glutathione accumulation, lung injury, and mortality in rats exposed to hyperoxia.

Authors:  C W White; P Ghezzi; C A Dinarello; S A Caldwell; I F McMurtry; J E Repine
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

8.  Recombinant murine interleukin-1 alpha enhancement of nonspecific antibacterial resistance.

Authors:  C J Czuprynski; J F Brown
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

9.  Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro.

Authors:  C A Dinarello; T Ikejima; S J Warner; S F Orencole; G Lonnemann; J G Cannon; P Libby
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

10.  Cytokine appearance in human endotoxemia and primate bacteremia.

Authors:  D G Hesse; K J Tracey; Y Fong; K R Manogue; M A Palladino; A Cerami; G T Shires; S F Lowry
Journal:  Surg Gynecol Obstet       Date:  1988-02
View more
  54 in total

1.  Some pharmacokinetic parameters and dosage regimens for a long-acting formulation of oxytetracycline in 6- to 8-month-old male calves.

Authors:  R Kumar; J K Malik
Journal:  Vet Res Commun       Date:  1998-12       Impact factor: 2.459

Review 2.  Pathogenesis of sepsis: new concepts and implications for future treatment.

Authors:  Pierre-Yves Bochud; Thierry Calandra
Journal:  BMJ       Date:  2003-02-01

Review 3.  Keratinocyte-derived tumor necrosis factor and the physiopathology of the skin.

Authors:  P F Piguet
Journal:  Springer Semin Immunopathol       Date:  1992

4.  Effect of SDZ MRL 953 on the survival of mice with advanced sepsis that cannot be cured by antibiotics alone.

Authors:  C Lam; E Schütze; E Liehl; P Stütz
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

5.  A novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor alpha gene expression: molecular cloning, sequencing, characterization, and chromosomal assignment.

Authors:  F Myokai; S Takashiba; R Lebo; S Amar
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

6.  TNF-alpha is a mediator of the anti-inflammatory response in a human neonatal model of the non-septic shock syndrome.

Authors:  S Hassett; P Moynagh; D Reen
Journal:  Pediatr Surg Int       Date:  2006-01       Impact factor: 1.827

Review 7.  Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?

Authors:  Robert S Munford
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

8.  A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenes.

Authors:  Girish Ramachandran; Mohan E Tulapurkar; Kristina M Harris; Gila Arad; Anat Shirvan; Ronen Shemesh; Louis J Detolla; Cinzia Benazzi; Steven M Opal; Raymond Kaempfer; Alan S Cross
Journal:  J Infect Dis       Date:  2013-03-14       Impact factor: 5.226

9.  Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin.

Authors:  Reuben Ramphal; Viviane Balloy; Jeevan Jyot; Amrisha Verma; Mustapha Si-Tahar; Michel Chignard
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  Beneficial or deleterious effects of a preexisting hypersensitivity to bacterial components on the course and outcome of infection.

Authors:  Marina Gumenscheimer; Ivan Mitov; Chris Galanos; Marina A Freudenberg
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.